Evidence-driven therapy and assessment portfolio powered by medical-grade software, tailored interactive content, and proprietary peripherals
Medicine
Next-generation evidence-based, protocolised therapies designed for true restoration of motor, cognitive and cardiovascular function following neural injuries, degeneration & ageing
Care
Therapies & technologies that enable clinicians to maximise the delivery of motor and cognitive neurorehabilitation across the continuum of care
Monitor
Diversified digital assessments for high fidelity, reliable quantification of motor and cognitive recovery in patients
“By decoding the mysteries of the brain, we are not only transforming the lives of people with neurological conditions, but the world as we know it.”
Tej Tadi, Founder, MindMaze
Deployed in leading centres around the world, our commercially available digital therapeutics are having a profound impact on the lives of patients and caregivers alike.
0
years of cutting-edge brain technology innovations
0
DTX Rx by 2026
0
Countries
>0k
Sessions delivered
0
Regulatory approvals
0
Issued and pending patents owned by MindMaze
0+
Indications including Stroke, Parkinson’s, TBI, MCI
>0
Papers. conference proceedings, trials, studies
0st
of its kind CAT 3 code
MindMaze Labs applies advanced neuroscience to everyday life
From F1 teams to fashion houses and electronics firms, we are partnering with leading global brands to create innovative products that bring our neuroscience expertise to new audiences.